David Wallace

Data Executive Summary September saw the extreme price rises of the last few months subside in the UK, albeit still seeing a handful of treble-digit percentage average increases for products like telmisartan. Source: Alamy After several consecutive months that have seen our Biggest Risers tables filled with treble-digit percentage average price rises, the UK generics market seems to have calmed slightly in September 2024, according to the latest figures from WaveData.

News Executive Summary Sandoz, Adalvo and Eurofarma were the biggest winners at the Global Generics & Biosimilars Awards 2024, each taking multiple honors, among the many champions named across 14 separate categories at our prizegiving ceremony in Milan. Source: Shutterstock In a blowout year that saw three separate companies each achieve multiple honors, Sandoz emerged as the biggest winner of the Global Generics & Biosimilars Awards 2024, sponsored by IQVIA.

Interviews Executive Summary As Sandoz publishes a report on US drug shortages, including a call for policy and other improvements, the firm’s North America head and AAM Chair Keren Haruvi discussed potential solutions to ongoing supply-chain failures. Source: Shutterstock Existing Subscriber? Sign in to continue reading. New to Pink Sheet? Start a free trial today!